Back to Results
First PageMeta Content
Aldosterone antagonists / Amines / Electrolyte disturbances / Nephrology / Potassium / Eplerenone / ACE inhibitor / Spironolactone / Statin / Chemistry / Medicine / Organic chemistry


INSPRA (eplerenone) tablets Initial U.S. Approval: 2002 • Concomitant use with strong CYP3A4 inhibitors (4, 7.1) For the treatment of hypertension: • Type 2 diabetes with microalbuminuria (4)
Add to Reading List

Document Date: 2009-03-31 14:09:46


Open Document

File Size: 376,87 KB

Share Result on Facebook
UPDATE